Endogenous opioidergic dysregulation of pain in fibromyalgia: a PET and fMRI study

Abstract Endogenous opioid system dysfunction potentially contributes to chronic pain in fibromyalgia (FM), but it is unknown if this dysfunction is related to established neurobiological markers of hyperalgesia. We previously reported that µ-opioid receptor (MOR) availability was reduced in patients with FM as compared with healthy controls in several pain-processing brain regions. In the present study, we compared pain-evoked functional magnetic resonance imaging with endogenous MOR binding and clinical pain ratings in female opioid-naive patients with FM (n = 18) using whole-brain analyses and regions of interest from our previous research. Within antinociceptive brain regions, including the dorsolateral prefrontal cortex (r = 0.81, P < 0.001) and multiple regions of the anterior cingulate cortex (all r > 0.67; all P < 0.02), reduced MOR availability was associated with decreased pain-evoked neural activity. Additionally, reduced MOR availability was associated with lower brain activation in the nucleus accumbens (r = 0.47, P = 0.050). In many of these regions, pain-evoked activity and MOR binding potential were also associated with lower clinical affective pain ratings. These findings are the first to link endogenous opioid system tone to regional pain-evoked brain activity in a clinical pain population. Our data suggest that dysregulation of the endogenous opioid system in FM could lead to less excitation in antinociceptive brain regions by incoming noxious stimulation, resulting in the hyperalgesia and allodynia commonly observed in this population. We propose a conceptual model of affective pain dysregulation in FM.

[1]  David Borsook,et al.  Test–retest reliability of evoked heat stimulation BOLD fMRI , 2015, Journal of Neuroscience Methods.

[2]  Stephanie E. Moser,et al.  Pressure Pain Sensitivity in Patients With Suspected Opioid-Induced Hyperalgesia , 2015, Regional Anesthesia & Pain Medicine.

[3]  H. Fields,et al.  Endogenous Opioid Activity in the Anterior Cingulate Cortex Is Required for Relief of Pain , 2015, The Journal of Neuroscience.

[4]  F. Huang,et al.  Activation of mu-opioid receptors in the ventrolateral orbital cortex inhibits the GABAergic miniature inhibitory postsynaptic currents in rats , 2015, Neuroscience Letters.

[5]  T. Lamer,et al.  Opioid-induced hyperalgesia in community-dwelling adults with chronic pain , 2015, Pain.

[6]  David A. Williams,et al.  Long-term Evaluation of Opioid Treatment in Fibromyalgia , 2015, The Clinical journal of pain.

[7]  B. Rosen,et al.  Simultaneous fMRI–PET of the opioidergic pain system in human brain , 2014, NeuroImage.

[8]  Heidi M. Schambra,et al.  Building up Analgesia in Humans via the Endogenous μ-Opioid System by Combining Placebo and Active tDCS: A Preliminary Report , 2014, PloS one.

[9]  K. Oda,et al.  Basal μ-opioid receptor availability in the amygdala predicts the inhibition of pain-related brain activity during heterotopic noxious counter-stimulation , 2014, Neuroscience Research.

[10]  Richard E. Harris,et al.  Pregabalin Rectifies Aberrant Brain Chemistry, Connectivity, and Functional Response in Chronic Pain Patients , 2013, Anesthesiology.

[11]  J. Ibinson,et al.  Pain does not follow the boxcar model: temporal dynamics of the BOLD fMRI signal during constant current painful electric nerve stimulation. , 2013, The journal of pain : official journal of the American Pain Society.

[12]  M. Fitzcharles,et al.  Opioid Use in Fibromyalgia Is Associated with Negative Health Related Measures in a Prospective Cohort Study , 2013, Pain research and treatment.

[13]  Sean Mackey,et al.  Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels. , 2013, Arthritis and rheumatism.

[14]  M. Angst,et al.  Analgesic tolerance without demonstrable opioid-induced hyperalgesia: A double-blinded, randomized, placebo-controlled trial of sustained-release morphine for treatment of chronic nonradicular low-back pain , 2012, PAIN®.

[15]  U. Pesonen,et al.  Striatal μ-opioid receptor availability predicts cold pressor pain threshold in healthy human subjects , 2012, Neuroscience Letters.

[16]  Daniel J. Clauw,et al.  Imaging central neurochemical alterations in chronic pain with proton magnetic resonance spectroscopy , 2012, Neuroscience Letters.

[17]  Richard E. Harris,et al.  Reduced insular γ-aminobutyric acid in fibromyalgia. , 2012, Arthritis and rheumatism.

[18]  Peter Fransson,et al.  Patients with fibromyalgia display less functional connectivity in the brain’s pain inhibitory network , 2012, Molecular pain.

[19]  E. Laboureyras,et al.  Endogenous opioids released during non-nociceptive environmental stress induce latent pain sensitization Via a NMDA-dependent process. , 2011, The journal of pain : official journal of the American Pain Society.

[20]  D. Clauw,et al.  Fibromyalgia: from pathophysiology to therapy , 2011, Nature Reviews Rheumatology.

[21]  M. McDonagh,et al.  The American College of Rheumatology 1990 criteria for the classification of fibromyalgia , 2011 .

[22]  S. Harte,et al.  Functional interaction between medial thalamus and rostral anterior cingulate cortex in the suppression of pain affect , 2011, Neuroscience.

[23]  Steven C. R. Williams,et al.  Evidence of dysfunctional pain inhibition in Fibromyalgia reflected in rACC during provoked pain , 2009, PAIN®.

[24]  Shuxing Wang,et al.  Altered quantitative sensory testing outcome in subjects with opioid therapy , 2009, Pain.

[25]  J. Younger,et al.  Effects of Naltrexone on Pain Sensitivity and Mood in Fibromyalgia: No Evidence for Endogenous Opioid Pathophysiology , 2009, PloS one.

[26]  A. May,et al.  Habituation to painful stimulation involves the antinociceptive system - a 1-year follow-up of 10 participants , 2008, PAIN.

[27]  Randy L. Gollub,et al.  A combined [11C]diprenorphine PET study and fMRI study of acupuncture analgesia , 2008, Behavioural Brain Research.

[28]  J. Vry,et al.  Differential effects of morphine on the affective and the sensory component of carrageenan-induced nociception in the rat , 2008, PAIN.

[29]  Laxmaiah Manchikanti,et al.  Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. , 2008, Pain physician.

[30]  Robert A Koeppe,et al.  Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. , 2008, Archives of general psychiatry.

[31]  B. Shyu,et al.  Differential regulation of morphine antinociceptive effects by endogenous enkephalinergic system in the forebrain of mice , 2008, Molecular pain.

[32]  P. Calabresi,et al.  Sensitization, glutamate, and the link between migraine and fibromyalgia , 2007, Current pain and headache reports.

[33]  Daniel J Clauw,et al.  Decreased Central μ-Opioid Receptor Availability in Fibromyalgia , 2007, The Journal of Neuroscience.

[34]  Ramon Casanova,et al.  Biological parametric mapping: A statistical toolbox for multimodality brain image analysis , 2007, NeuroImage.

[35]  I. Tracey,et al.  Pharmacological FMRI in the development of new analgesic compounds , 2006, NMR in biomedicine.

[36]  Martin S. Angst,et al.  Opioid-induced Hyperalgesia: A Qualitative Systematic Review , 2006, Anesthesiology.

[37]  C. Weiller,et al.  Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network , 2006, Pain.

[38]  Daniel J Clauw,et al.  A chronic fatigue syndrome – related proteome in human cerebrospinal fluid , 2005, BMC neurology.

[39]  Thomas E. Nichols,et al.  Placebo Effects Mediated by Endogenous Opioid Activity on μ-Opioid Receptors , 2005, The Journal of Neuroscience.

[40]  David A. Williams,et al.  Differences in unpleasantness induced by experimental pressure pain between patients with fibromyalgia and healthy controls , 2005, European journal of pain.

[41]  David A. Williams,et al.  The relationship between depression, clinical pain, and experimental pain in a chronic pain cohort. , 2005, Arthritis and rheumatism.

[42]  D. Clauw,et al.  Cerebrospinal fluid levels of opioid peptides in fibromyalgia and chronic low back pain , 2004, BMC musculoskeletal disorders.

[43]  D. Clauw,et al.  Pain catastrophizing and neural responses to pain among persons with fibromyalgia. , 2004, Brain : a journal of neurology.

[44]  Jason Steffener,et al.  Functional imaging of pain in patients with primary fibromyalgia. , 2004, The Journal of rheumatology.

[45]  J. Mao,et al.  Opioid therapy for chronic pain. , 2003, The New England journal of medicine.

[46]  S. Minoshima,et al.  Keeping pain out of mind: the role of the dorsolateral prefrontal cortex in pain modulation. , 2003, Brain : a journal of neurology.

[47]  J. Mao.  Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy , 2002, Pain.

[48]  Daniel J Clauw,et al.  Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. , 2002, Arthritis and rheumatism.

[49]  D. Jewett.  A simple synthesis of [11C]carfentanil using an extraction disk instead of HPLC. , 2001, Nuclear medicine and biology.

[50]  Joshua A. Bueller,et al.  Regional Mu Opioid Receptor Regulation of Sensory and Affective Dimensions of Pain , 2001, Science.

[51]  K. Miczek,et al.  Alterations within the endogenous opioid system in mice with targeted deletion of the neutral endopeptidase (‘enkephalinase’) gene , 2000, Regulatory Peptides.

[52]  Yuji Ikegaya,et al.  Morphine augments excitatory synaptic transmission in the dentate gyrus through GABAergic disinhibition , 2000, Neuroscience Research.

[53]  L. Chiou,et al.  Mechanism underlying increased neuronal activity in the rat ventrolateral periaqueductal grey by a μ‐opioid , 1999, The Journal of physiology.

[54]  I. Russell,et al.  Increased concentrations of nerve growth factor in cerebrospinal fluid of patients with fibromyalgia. , 1999, The Journal of rheumatology.

[55]  N. Volkow,et al.  Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[56]  G. Uhl,et al.  Chronic opioid antagonist administration upregulates mu opioid receptor binding without altering mu opioid receptor mRNA levels. , 1995, Brain research. Molecular brain research.

[57]  J. García-Sevilla,et al.  Increased density of μ-opioid receptors in the postmortem brain of suicide victims , 1995, Brain Research.

[58]  D. Price,et al.  Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain , 1995, Pain.

[59]  S. Luthra,et al.  Changes in central opioid receptor binding in relation to inflammation and pain in patients with rheumatoid arthritis. , 1994, British journal of rheumatology.

[60]  M. Mintun,et al.  Automated detection of the intercommissural line for stereotactic localization of functional brain images. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[61]  I. Russell,et al.  Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. , 1992, Arthritis and rheumatism.

[62]  J. Gybels,et al.  Morphine differentially affects the sensory and affective pain ratings in neurogenic and idiopathic forms of pain , 1991, Pain.

[63]  Anat Biegon,et al.  Regionally selective increases in μ opioid receptor density in the brains of suicide victims , 1990, Brain Research.

[64]  P. Tugwell,et al.  The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. , 1990, Arthritis and rheumatism.

[65]  R. Dubner,et al.  A multiple random staircase method of psychophysical pain assessment , 1988, Pain.

[66]  Ronald Melzack,et al.  The short-form McGill pain questionnaire , 1987, Pain.

[67]  H. Fields,et al.  Role of pain in placebo analgesia. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[68]  L. Radloff.  The CES-D Scale , 1977 .

[69]  F. J. Ballina García,et al.  [Fibromyalgia. Clinical review]. , 1995, Revista clinica espanola.